Related Experiment Video
Updated: Jul 11, 2025

Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
Hypoxia signaling and metastatic progression
Luana Schito1, Sergio Rey-Keim1
1UCD School of Medicine, Belfield, Dublin D04 C7X2, Ireland; UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, Dublin D04 C7X2, Ireland.
Tumor hypoxia, a lack of oxygen during cancer growth, drives aggressive cancer cell phenotypes and metastasis. Targeting hypoxia signaling pathways offers a promising strategy to combat cancer spread and improve patient outcomes.
Area of Science:
- Oncology
- Cancer Biology
- Tumor Microenvironment
Background:
- Disruption of oxygen homeostasis (imbalance in O2 supply and demand) occurs during malignant proliferation.
- This imbalance leads to the development of hypoxic tumor microenvironments.
- Hypoxic conditions promote aggressive cancer cell phenotypes linked to metastasis and patient mortality.
Purpose of the Study:
- To present the mechanistic links between tumor hypoxia and metastatic progression.
- To emphasize current strategies and future perspectives for targeting hypoxia signaling pathways.
- To highlight the potential of these strategies in halting cancer cell metastatic activities.
Main Methods:
- This is a review article.
- Mechanistic links were analyzed from existing literature.
- Current therapeutic strategies and future perspectives were evaluated.
Main Results:
- Tumor hypoxia is a key driver of cancer cell aggressiveness and metastasis.
- Specific hypoxia-inducible factors and signaling pathways are implicated in promoting metastatic phenotypes.
- Targeting these pathways has shown potential in preclinical and clinical studies.
Conclusions:
- Understanding the link between tumor hypoxia and metastasis is crucial for developing effective cancer therapies.
- Targeting hypoxia signaling pathways represents a promising therapeutic strategy to inhibit cancer metastasis.
- Further research into hypoxia-driven mechanisms can lead to novel anti-metastatic treatments.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Non-Canonical Wnt Signaling Pathways
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
PI3K/mTOR/AKT Signaling Pathway

